Thomas Volkmer

Title: Thomas Volkmer: Innovator in Pharmaceutical Dosage Forms

Introduction

Thomas Volkmer is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. His work focuses on improving the efficacy and delivery of medications.

Latest Patents

Thomas Volkmer holds a patent for a pharmaceutical dosage form that comprises nifedipine or nisoldipine combined with an angiotensin II antagonist and/or a diuretic. This invention is characterized by the controlled release of nifedipine or nisoldipine in the body, while the angiotensin II antagonist and/or diuretic is released rapidly. The patent outlines processes for the preparation of these dosage forms and their use as medicaments for the prophylaxis, secondary prophylaxis, or treatment of various disorders.

Career Highlights

Volkmer is associated with Bayer Intellectual Property GmbH, where he continues to advance his research and development efforts. His work has contributed to the enhancement of pharmaceutical formulations, making them more effective for patients.

Collaborations

He has collaborated with notable colleagues, including Alexander Kuhl and Erich Brendel, to further his research initiatives and patent developments.

Conclusion

Thomas Volkmer's innovative work in pharmaceutical dosage forms exemplifies the importance of research and development in the medical field. His contributions are paving the way for more effective treatments for patients.